EnBiotix / Seres Healthcare / Unifying SynBio’s Stakeholders Through Capital / Selventa / Synereca Pharmaceuticals / Jim / Goldman Sachs & Co. / Ensof / Joule Unlimited / LifeWave Ltd / Sample6 Technologies / On-Point Capital LLC / Research-Stimulus Without Risk Capital / /
Country
Australia / /
Currency
USD / / /
EntertainmentAwardEvent
Director's Pioneer Award / /
Facility
Oxford University / Boston University / Wyss Institute / At Boston University / University of Queensland / Institute of Medicine / Harvard University / /
IndustryTerm
expert venture capital funds / select / investment services / client services / physiological and biological systems / /
Founding Faculty / Wyss Institute / DEVELOP ASSETS MITIGATE RISKS IDENTIFY OPPORTUNTIES RESEARCH & COMMERCIALIZATION EVALUATE OPPORTUNITIES CORPORATE INNOVATION GOVERNMENT / Harvard University / Scientific Advisory Board / Center of Synthetic Biology / University of Queensland / National Academy of Engineering / National Academy of Inventors / American Academy of Arts & Sciences / Institute of Medicine of the National Academies / Oxford University / Boston University / Howard Hughes Medical Institute / /
Investigator / CEO / Professor / Tutor / Director / Chief Executive Officer / Professor of Biomedical Engineering / Professor of Medicine / and Co-Director and Co-Founder / Investigator / Howard Hughes Med / Professor / Professor of Biomedical Engineering / Professor of Medicine / and Co-Director / CFO and director / /
ProvinceOrState
Queensland / /
PublishedMedium
the Scientific American / the Technology Review / /
Specialized Capital Formation and Deployment to Support Synthetic Biology Denver Dale, Ph.D. Founder, Chief Executive Officer [removed]